ArticleJournal of experimental & clinical cancer research : CR2018

Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.

Xiaoting Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.